Private Practitioner, 3 Rue du Dr François Broussais 17100 Saintes, France, Faculté d'Odontologie, Université de Lyon, Université Claude Bernard Lyon 1, 11 rue Guillaume Paradin, 69008 Lyon, France.
Clinical Doctor, Chirurgie Maxillo-faciale, Hôpital Nord-Ouest, Plateau d'Ouilly 69400 Gleizé Villefranche sur Saône, France.
J Stomatol Oral Maxillofac Surg. 2022 Apr;123(2):233-238. doi: 10.1016/j.jormas.2021.04.007. Epub 2021 Apr 30.
Processed nerve allografts (PNA) are an alternative to nerve autografts to reconstruct the inferior alveolar nerve (IAN) when it is damaged. The purpose of this study was to report the results of IAN reconstruction using PNA in the context of aggressive benign mandibular pathology.
A systematic literature review was performed according to the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) statement through the MEDLINE (Pubmed) and SCOPUS (Elsevier) databases. Studies concerning reconstructive surgeries of IAN by PNA, performed at the same time as the surgical resection of the benign pathologies of the mandible were included. The following data were analyzed: gender and patient age, cause of mandibular resection, graft dimensions, sensory recovery at least 6 months after surgery according to the MRC scale, and adverse events related to the intervention.
The initial search yielded 290 studies and 5 were included in the final review. A total of 33 patients underwent 36 IAN reconstructions; 14 patients were female (42.4%) and mean age was 30 years old. The mean length of graft used was 64.0 ± 9.1 mm. The most common pathology that led to nerve resection was ameloblastoma (52%). Among the reconstructions for which follow-up data were available, functional sensory recovery occurred in 92.9% of cases.
PNA are a reliable, safe, and effective alternative to nerve autografts for the rehabilitation of the IAN with 92.9% of functional recovery according to the reported literature, avoiding any comorbidity associated with the use of a donor site.
在损伤下牙槽神经(IAN)时,处理过的异体神经移植物(PNA)是神经自体移植物的替代物。本研究的目的是报告在侵袭性良性下颌骨病理学背景下使用 PNA 进行 IAN 重建的结果。
根据系统评价和荟萃分析的首选报告项目(PRISMA)声明,通过 MEDLINE(PubMed)和 SCOPUS(Elsevier)数据库进行系统文献综述。研究对象为同时进行良性下颌骨切除术和 PNA 重建术的 IAN 修复手术。分析的数据包括:性别和患者年龄、下颌骨切除术的原因、移植物尺寸、根据 MRC 量表手术后至少 6 个月的感觉恢复情况,以及与干预相关的不良事件。
最初的搜索产生了 290 项研究,最终有 5 项研究被纳入综述。共有 33 名患者接受了 36 次 IAN 重建;14 名患者为女性(42.4%),平均年龄为 30 岁。使用的移植物平均长度为 64.0±9.1mm。导致神经切除的最常见疾病是成釉细胞瘤(52%)。在有随访数据的重建中,92.9%的病例出现了功能性感觉恢复。
根据文献报道,PNA 是一种可靠、安全、有效的 IAN 康复替代物,其功能性恢复率为 92.9%,避免了使用供体部位相关的任何合并症。